IVD Quality Control Market to Hit $2.2B by 2031 as Automation Drives Growth

  • The global IVD quality control market is projected to grow from $1.7B in 2026 to $2.2B by 2031, a CAGR of 5.3%.
  • Growth is driven by rising testing volumes, regulatory requirements, and the shift to automated QC workflows.
  • Roche's navify Lab Operations platform exemplifies the move towards integrated QC management and real-time monitoring.
  • Asia-Pacific is the fastest-growing region, with expanding diagnostic infrastructure and laboratory automation.
  • Siemens Healthineers earned the My Green Lab ACT Ecolabel for its Atellica analyzers and reagents in July 2025.

The IVD quality control market is evolving from a standalone compliance task to an integrated part of laboratory operations. This shift is driven by the increasing complexity of diagnostic testing, regulatory requirements, and the need for real-time quality monitoring. The market's growth is further fueled by the expansion of decentralized and point-of-care testing, creating demand for simplified QC products and quality-management systems.

Automation Integration
How the shift from manual to automated QC workflows will impact laboratory efficiency and accuracy.
Regulatory Compliance
Whether laboratories can sustain the implementation costs of digital QC systems and staff training.
Market Expansion
The pace at which Asia-Pacific can grow its diagnostic infrastructure to support the rising demand for QC solutions.